• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

五氧化二钒可差异化调节真皮成纤维细胞中 CXCL8 和 CXCL11 趋化因子的分泌。

CXCL8 and CXCL11 chemokine secretion in dermal fibroblasts is differentially modulated by vanadium pentoxide.

机构信息

Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, I‑56126 Pisa, Italy.

Department of Clinical and Experimental Medicine, School of Medicine, University of Pisa, I‑56126 Pisa, Italy.

出版信息

Mol Med Rep. 2018 Aug;18(2):1798-1803. doi: 10.3892/mmr.2018.9121. Epub 2018 Jun 1.

DOI:10.3892/mmr.2018.9121
PMID:29901202
Abstract

An increase in skin rashes or atopic dermatitis has been observed in individuals working with vanadium. However, to the best of our knowledge no in vivo or in vitro studies have evaluated the effect of exposure to vanadium in dermal fibroblasts. Cells viability and proliferation were assessed by WST‑1 assay, cells were treated with increasing concentrations of V2O5 (1, 10 and 100 nM). CXCL8 and CXCL11 concentrations were measured in the supernatants using an ELISA assay. V2O5 was not observed as having a significant effect on dermal fibroblast's viability and proliferation. However, it was revealed that V2O5 was able to induce the secretion of CXCL8 and CXCL11 chemokines into dermal fibroblasts. V2O5 synergistically increased the effect of interferon (IFN)γ on CXCL11 secretion. In addition, V2O5 synergistically increased the effect of the tumor necrosis factor α on CXCL8 secretion and abolished the inhibitory effect of IFNγ. V2O5 induction of CXCL8 and CXCL11 chemokines may lead to the appearance and perpetuation of an inflammatory reaction into the dermal tissue. Further studies are required to evaluate dermal integrity and manifestations in subjects occupationally exposed, or living in polluted areas.

摘要

据观察,接触钒的个体皮肤疹或特应性皮炎的发病率有所增加。但是,据我们所知,尚无研究评估过暴露于五氧化二钒对真皮成纤维细胞的影响。通过 WST-1 检测法评估细胞活力和增殖,用不同浓度的 V2O5(1、10 和 100 nM)处理细胞。采用 ELISA 检测法测量上清液中 CXCL8 和 CXCL11 的浓度。结果表明,V2O5 对真皮成纤维细胞的活力和增殖没有显著影响。然而,V2O5 能够诱导真皮成纤维细胞分泌趋化因子 CXCL8 和 CXCL11。V2O5 还协同增强了干扰素 (IFN)γ对 CXCL11 分泌的作用。此外,V2O5 协同增强了肿瘤坏死因子 α对 CXCL8 分泌的作用,并消除了 IFNγ 的抑制作用。V2O5 诱导的 CXCL8 和 CXCL11 趋化因子的产生可能导致真皮组织中炎症反应的出现和持续存在。需要进一步研究评估职业暴露或生活在污染地区的人群的皮肤完整性和表现。

相似文献

1
CXCL8 and CXCL11 chemokine secretion in dermal fibroblasts is differentially modulated by vanadium pentoxide.五氧化二钒可差异化调节真皮成纤维细胞中 CXCL8 和 CXCL11 趋化因子的分泌。
Mol Med Rep. 2018 Aug;18(2):1798-1803. doi: 10.3892/mmr.2018.9121. Epub 2018 Jun 1.
2
Differential modulation by vanadium pentoxide of the secretion of CXCL8 and CXCL11 chemokines in thyroid cells.五氧化二钒对甲状腺细胞中 CXCL8 和 CXCL11 趋化因子分泌的差异调节。
Mol Med Rep. 2018 May;17(5):7415-7420. doi: 10.3892/mmr.2018.8764. Epub 2018 Mar 16.
3
Induction of Th1 chemokine secretion in dermal fibroblasts by vanadium pentoxide.五氧化二钒诱导真皮成纤维细胞分泌 Th1 趋化因子。
Mol Med Rep. 2018 May;17(5):6914-6918. doi: 10.3892/mmr.2018.8712. Epub 2018 Mar 9.
4
Vanadium pentoxide induces the secretion of CXCL9 and CXCL10 chemokines in thyroid cells.五氧化二钒可诱导甲状腺细胞分泌 CXCL9 和 CXCL10 趋化因子。
Oncol Rep. 2018 May;39(5):2422-2426. doi: 10.3892/or.2018.6307. Epub 2018 Mar 8.
5
Vanadium pentoxide prevents NK-92MI cell proliferation and IFNγ secretion through sustained JAK3 phosphorylation.五氧化二钒通过持续的JAK3磷酸化来阻止NK-92MI细胞增殖和IFNγ分泌。
J Immunotoxicol. 2016;13(1):27-37. doi: 10.3109/1547691X.2014.996681. Epub 2015 Jan 7.
6
Monokine induced by interferon gamma (IFNgamma) (CXCL9) and IFNgamma inducible T-cell alpha-chemoattractant (CXCL11) involvement in Graves' disease and ophthalmopathy: modulation by peroxisome proliferator-activated receptor-gamma agonists.γ干扰素(IFNγ)诱导的单核因子(CXCL9)和IFNγ诱导的T细胞α趋化因子(CXCL11)在格雷夫斯病和眼病中的作用:过氧化物酶体增殖物激活受体γ激动剂的调节作用
J Clin Endocrinol Metab. 2009 May;94(5):1803-9. doi: 10.1210/jc.2008-2450. Epub 2009 Mar 10.
7
Interleukin-27 and IFNγ regulate the expression of CXCL9, CXCL10, and CXCL11 in hepatitis.白细胞介素-27和干扰素γ调节肝炎中CXCL9、CXCL10和CXCL11的表达。
J Mol Med (Berl). 2015 Dec;93(12):1355-67. doi: 10.1007/s00109-015-1319-6. Epub 2015 Jul 23.
8
Synergistic induction of CXCL9 and CXCL11 by Toll-like receptor ligands and interferon-gamma in fibroblasts correlates with elevated levels of CXCR3 ligands in septic arthritis synovial fluids.Toll样受体配体和干扰素-γ在成纤维细胞中协同诱导CXCL9和CXCL11,这与脓毒性关节炎滑液中CXCR3配体水平升高相关。
J Leukoc Biol. 2004 May;75(5):777-84. doi: 10.1189/jlb.1003524. Epub 2004 Mar 2.
9
Eotaxin/CCL11 suppresses IL-8/CXCL8 secretion from human dermal microvascular endothelial cells.嗜酸性粒细胞趋化因子/CCL11抑制人真皮微血管内皮细胞分泌白细胞介素-8/CXCL8。
J Immunol. 2002 Mar 15;168(6):2887-94. doi: 10.4049/jimmunol.168.6.2887.
10
Evaluation of CXCL8, CXCL10, CXCL11, CXCL12 and CXCL13 in serum and cerebrospinal fluid of patients with neuroborreliosis.评价神经莱姆病患者血清和脑脊液中 CXCL8、CXCL10、CXCL11、CXCL12 和 CXCL13 的水平。
Immunol Lett. 2014 Jan-Feb;157(1-2):45-50. doi: 10.1016/j.imlet.2013.11.002. Epub 2013 Nov 12.

引用本文的文献

1
Therapeutic Effects of Makino Against Atopic Dermatitis-Like Skin Inflammation Through the JAK2/STAT Signaling Pathway.牧野氏疗法通过JAK2/STAT信号通路对特应性皮炎样皮肤炎症的治疗作用。
Int J Mol Sci. 2025 Apr 28;26(9):4191. doi: 10.3390/ijms26094191.
2
Pathogenic Th2 Cytokine Profile Skewing by IFN-γ-Responding Vitiligo Fibroblasts via CCL2/CCL8.IFN-γ-应答的白癜风成纤维细胞通过 CCL2/CCL8 导致致病性 Th2 细胞因子谱偏斜。
Cells. 2023 Jan 4;12(2):217. doi: 10.3390/cells12020217.
3
Vanadium as potential therapeutic agent for COVID-19: A focus on its antiviral, antiinflamatory, and antihyperglycemic effects.
钒作为治疗 COVID-19 的潜在药物:关注其抗病毒、抗炎和降血糖作用。
J Trace Elem Med Biol. 2022 Jan;69:126887. doi: 10.1016/j.jtemb.2021.126887. Epub 2021 Oct 29.
4
Interplay between ESKAPE Pathogens and Immunity in Skin Infections: An Overview of the Major Determinants of Virulence and Antibiotic Resistance.皮肤感染中ESKAPE病原体与免疫的相互作用:毒力和抗生素耐药性主要决定因素概述
Pathogens. 2021 Feb 2;10(2):148. doi: 10.3390/pathogens10020148.